Phibro Animal Health Co. (NASDAQ:PAHC) Stock Holdings Lifted by Jacobs Levy Equity Management Inc.

by · The Markets Daily

Jacobs Levy Equity Management Inc. lifted its position in Phibro Animal Health Co. (NASDAQ:PAHC – Free Report) by 56.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 301,173 shares of the company’s stock after acquiring an additional 108,918 shares during the period. Jacobs Levy Equity Management Inc. owned about 0.74% of Phibro Animal Health worth $6,325,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the company. Graham Capital Management L.P. purchased a new position in shares of Phibro Animal Health in the fourth quarter worth approximately $245,000. Deutsche Bank AG increased its position in shares of Phibro Animal Health by 90.8% in the fourth quarter. Deutsche Bank AG now owns 16,873 shares of the company’s stock worth $354,000 after acquiring an additional 8,032 shares in the last quarter. Cubist Systematic Strategies LLC purchased a new position in shares of Phibro Animal Health in the fourth quarter worth approximately $1,119,000. CastleKnight Management LP increased its position in shares of Phibro Animal Health by 6.2% in the fourth quarter. CastleKnight Management LP now owns 389,433 shares of the company’s stock worth $8,178,000 after acquiring an additional 22,796 shares in the last quarter. Finally, Cetera Investment Advisers purchased a new position in shares of Phibro Animal Health in the fourth quarter worth approximately $204,000. 99.34% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts recently commented on PAHC shares. StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Morgan Stanley raised their price target on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an “equal weight” rating in a report on Thursday, May 8th. Finally, Barclays raised their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $20.00.

Check Out Our Latest Stock Report on PAHC

Phibro Animal Health Trading Up 0.4%

NASDAQ:PAHC opened at $24.60 on Wednesday. Phibro Animal Health Co. has a 12 month low of $16.16 and a 12 month high of $26.55. The firm has a market cap of $996.37 million, a price-to-earnings ratio of 51.25, a P/E/G ratio of 0.45 and a beta of 0.62. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The company’s 50 day moving average is $20.04 and its 200-day moving average is $21.86.

Phibro Animal Health (NASDAQ:PAHC – Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.52 by $0.11. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. The company had revenue of $347.80 million for the quarter, compared to analyst estimates of $352.41 million. Equities analysts anticipate that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.95%. The ex-dividend date of this dividend is Wednesday, June 4th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 61.54%.

Phibro Animal Health Profile

(Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Read More